Phillip B. Donenberg
CIK 1238120 · SVP and CFO · last filed 2026-06-10
Phillip B. Donenberg is a SVP and CFO who has filed 41 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for TECX, was dated Jun 10, 2026. Across all open-market trades the lifetime net is +$161.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.38M
8
41
$161.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TECX | Director | — | $30.28 | — | $0 | 2 | 2026-06-10 |
| TSHA | Director | 241,289 | $5.71 | $1.38M | $123.3K | 9 | 2026-06-02 |
| SNSE | Director | — | $13.00 | — | $0 | 2 | 2026-04-14 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | 2,000 | $16.80 | $33.6K | $23.4K | 7 | 2023-06-08 |
| Assertio Therapeutics, Inc (DEPO) Delisted | SVP and CFO | — | — | — | $0 | 1 | 2018-07-16 |
| AveXis, Inc. (AVXS) Delisted | Chief Financial Officer | 3,800 | — | — | $0 | 3 | 2018-05-15 |
| ANI PHARMACEUTICALS INC (BPAX) Delisted | Sr VP of Finance, CFO, Secy | 44,322 | — | — | $14.9K | 13 | 2012-01-27 |
| ANI PHARMACEUTICALS INC (BPA) Delisted | CFO, Treasurer and Secretary | 35,822 | — | — | $0 | 2 | 2007-02-21 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | TECX | Grant (A) | — | $0 | EDGAR |
| 2026-06-02 | TSHA | Grant (A) | +21,335 | $0 | EDGAR |
| 2026-04-14 | SNSE | Grant (A) | — | $0 | EDGAR |
| 2026-02-17 | SNSE | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | TECX | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | TSHA | Grant (A) | +56,623 | $0 | EDGAR |
| 2024-06-24 | — | Grant (A) | — | $0 | |
| 2024-05-31 | TSHA | Grant (A) | +49,220 | $0 | EDGAR |
| 2023-08-16 | TSHA | Buy (P) | +111,111 | $100.0K | EDGAR |
| 2023-06-26 | TSHA | Grant (A) | — | $0 | EDGAR |